Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 2Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma, Follicular 2Pulmonary Disease, Chronic Obstructive 1Asthma 1

Interventions

Cyclophosphamide 17Rituximab 12Prednisone 7Peripheral Blood Stem Cell Transplantation 7Filgrastim 7sargramostim 6Vincristine 6fludarabine phosphate 5Radiotherapy 5Doxorubicin 5Cytarabine 5Cisplatin 5ibritumomab tiuxetan 4Methylprednisolone 4Melphalan 4Etoposide 4Dexamethasone 4Cyclosporine 4epratuzumab 3Sensitivity and Specificity 3Polymerase Chain Reaction 3Mycophenolic Acid 3Indium 3Chlorambucil 3Busulfan 3Bendamustine Hydrochloride 3Antilymphocyte Serum 3Antigens, CD19 3obinutuzumab 2fludarabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Lymphoma, Follicular × Fluticasone-Salmeterol Drug Combination × Clear all
NCT03387241 2019-04-29

Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Unknown
330 enrolled
Lymphoid

Asthma, Lymphoma, Follicular

NCT03745261 2018-11-19

Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD

Henan University of Traditional Chinese Medicine

Phase 3 Unknown
240 enrolled
Lymphoid

Lymphoma, Follicular, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡